Artikel mit Open-Access-Mandaten - Stefan Rose-JohnWeitere Informationen
Nicht verfügbar: 53
Prüfen
Interleukin-6 and its receptors: a highly regulated and dynamic system
J Wolf, S Rose-John, C Garbers
Cytokine 70 (1), 11-20, 2014
Mandate: Deutsche Forschungsgemeinschaft
Prüfen
Interleukin-6: Biology, signaling and strategies of blockade
F Schaper, S Rose-John
Cytokine & growth factor reviews 26 (5), 475-487, 2015
Mandate: Deutsche Forschungsgemeinschaft
Prüfen
Interleukin-6: designing specific therapeutics for a complex cytokine
C Garbers, S Heink, T Korn, S Rose-John
Nature reviews Drug discovery 17 (6), 395-412, 2018
Mandate: Deutsche Forschungsgemeinschaft, European Commission, Bundesministerium für …
Prüfen
ADAM17: a molecular switch to control inflammation and tissue regeneration
J Scheller, A Chalaris, C Garbers, S Rose-John
Trends in immunology 32 (8), 380-387, 2011
Mandate: Deutsche Forschungsgemeinschaft
Prüfen
The IL-6/gp130/STAT3 signaling axis: recent advances towards specific inhibition
C Garbers, S Aparicio-Siegmund, S Rose-John
Current opinion in immunology 34, 75-82, 2015
Mandate: Deutsche Forschungsgemeinschaft
Prüfen
Plasticity and cross-talk of interleukin 6-type cytokines
C Garbers, HM Hermanns, F Schaper, G Müller-Newen, J Grötzinger, ...
Cytokine & growth factor reviews 23 (3), 85-97, 2012
Mandate: Deutsche Forschungsgemeinschaft
Prüfen
IL-6 biology: implications for clinical targeting in rheumatic disease
LH Calabrese, S Rose-John
Nature Reviews Rheumatology 10 (12), 720-727, 2014
Mandate: Deutsche Forschungsgemeinschaft
Prüfen
Interleukin-6: from basic biology to selective blockade of pro-inflammatory activities
J Scheller, C Garbers, S Rose-John
Seminars in immunology 26 (1), 2-12, 2014
Mandate: Deutsche Forschungsgemeinschaft
Prüfen
The soluble Interleukin 6 receptor: generation and role in inflammation and cancer
A Chalaris, C Garbers, B Rabe, S Rose-John, J Scheller
European journal of cell biology 90 (6-7), 484-494, 2011
Mandate: Deutsche Forschungsgemeinschaft
Prüfen
STAT3 activation through IL-6/IL-11 in cancer-associated fibroblasts promotes colorectal tumour development and correlates with poor prognosis
C Heichler, K Scheibe, A Schmied, CI Geppert, B Schmid, S Wirtz, ...
Gut 69 (7), 1269-1282, 2020
Mandate: Deutsche Forschungsgemeinschaft
Prüfen
Elastin-like polypeptides revolutionize recombinant protein expression and their biomedical application
DM Floss, K Schallau, S Rose-John, U Conrad, J Scheller
Trends in biotechnology 28 (1), 37-45, 2010
Mandate: Deutsche Forschungsgemeinschaft
Prüfen
Therapeutic targeting of IL-6 trans signaling counteracts STAT3 control of experimental inflammatory arthritis
MA Nowell, AS Williams, SA Carty, J Scheller, AJ Hayes, GW Jones, ...
The Journal of Immunology 182 (1), 613-622, 2009
Mandate: Deutsche Forschungsgemeinschaft, Versus Arthritis, UK
Prüfen
IL-6 controls the innate immune response against Listeria monocytogenes via classical IL-6 signaling
J Hoge, I Yan, N Jänner, V Schumacher, A Chalaris, OM Steinmetz, ...
The Journal of Immunology 190 (2), 703-711, 2013
Mandate: Deutsche Forschungsgemeinschaft
Prüfen
The soluble interleukin 6 receptor: advanced therapeutic options in inflammation
S Rose‐John
Clinical Pharmacology & Therapeutics 102 (4), 591-598, 2017
Mandate: Deutsche Forschungsgemeinschaft, Bundesministerium für Bildung und Forschung
Prüfen
Interleukin-6 trans-signaling in inflammatory bowel disease
K Mitsuyama, M Sata, S Rose-John
Cytokine & growth factor reviews 17 (6), 451-461, 2006
Mandate: Deutsche Forschungsgemeinschaft
Prüfen
Interleukin-6: a villain in the drama of pancreatic cancer development and progression
R Holmer, FA Goumas, GH Waetzig, S Rose-John, H Kalthoff
Hepatobiliary & Pancreatic Diseases International 13 (4), 371-380, 2014
Mandate: Deutsche Forschungsgemeinschaft
Prüfen
Inhibition of IL‐6 signaling significantly reduces primary tumor growth and recurrencies in orthotopic xenograft models of pancreatic cancer
FA Goumas, R Holmer, JH Egberts, A Gontarewicz, C Heneweer, ...
International journal of cancer 137 (5), 1035-1046, 2015
Mandate: Deutsche Forschungsgemeinschaft
Prüfen
Impact of interleukin-6 classic-and trans-signaling on liver damage and regeneration
C Drucker, J Gewiese, S Malchow, J Scheller, S Rose-John
Journal of autoimmunity 34 (1), 29-37, 2010
Mandate: Deutsche Forschungsgemeinschaft
Prüfen
IL6 trans-signaling promotes KRAS-driven lung carcinogenesis
GD Brooks, L McLeod, S Alhayyani, A Miller, PA Russell, W Ferlin, ...
Cancer research 76 (4), 866-876, 2016
Mandate: National Health and Medical Research Council, Australia, Deutsche …
Prüfen
New insights into IL-6 family cytokines in metabolism, hepatology and gastroenterology
MD Giraldez, D Carneros, C Garbers, S Rose-John, M Bustos
Nature reviews Gastroenterology & hepatology 18 (11), 787-803, 2021
Mandate: Deutsche Forschungsgemeinschaft, Government of Spain
Angaben zur Publikation und Finanzierung werden automatisch von einem Computerprogramm ermittelt